MedPath

广州白云山花城药业有限公司

Ownership
-
Established
1986-04-17
Employees
-
Market Cap
-
Website
https://www.huachengzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

156

NMPA:156

Drug Approvals

生脉饮

Approval Number
国药准字Z44020137
Approval Date
Apr 26, 2024
NMPA

咳特灵胶囊

Approval Number
国药准字Z44020322
Approval Date
Apr 26, 2024
NMPA

保和颗粒

Approval Number
国药准字Z44020078
Approval Date
Apr 15, 2024
NMPA

维C银翘片

Approval Number
国药准字Z44020339
Approval Date
Apr 15, 2024
NMPA

鼻炎宁颗粒

Approval Number
国药准字Z44020079
Approval Date
Apr 15, 2024
NMPA

藿香清胃片

Approval Number
国药准字Z44020161
Approval Date
Apr 15, 2024
NMPA

清脑复神液

Approval Number
国药准字Z44020324
Approval Date
Apr 15, 2024
NMPA

感冒清片

Approval Number
国药准字Z44020130
Approval Date
Apr 15, 2024
NMPA

腹可安片

Approval Number
国药准字Z20025313
Approval Date
Apr 15, 2024
NMPA

藿胆丸

Approval Number
国药准字Z44020160
Approval Date
Apr 15, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.